(a) The Department of Human Services shall ensure that the Arkansas Medicaid Program covers medications approved by the United States Food and Drug Administration for tobacco cessation, including without limitation: (1) Nicotine replacement therapy patches; (2) Nicotine replacement therapy gum; (3) Nicotine replacement therapy lozenges; (4) Nicotine replacement therapy nasal spray; (5) Nicotine replacement therapy inhalers; (6) Bupropion; and (7) Varenicline. (b) Prior authorization shall not be required for coverage of medications described in subsection (a) of this section. Added by Act 2019, No. 959,§ 2, eff. 7/24/2019. (a) The Department of Human Services shall ensure that the Arkansas Medicaid Program covers medications approved by the United States Food and Drug Administration for tobacco cessation, including without limitation: (1) Nicotine replacement therapy patches; (2) Nicotine replacement therapy gum; (3) Nicotine replacement therapy lozenges; (4) Nicotine replacement therapy nasal spray; (5) Nicotine replacement therapy inhalers; (6) Bupropion; and (7) Varenicline. (b) Prior authorization shall not be required for coverage of medications described in subsection (a) of this section. Added by Act 2019, No. 959,§ 2, eff. 7/24/2019. (a) The Department of Human Services shall ensure that the Arkansas Medicaid Program covers medications approved by the United States Food and Drug Administration for tobacco cessation, including without limitation: (1) Nicotine replacement therapy patches; (2) Nicotine replacement therapy gum; (3) Nicotine replacement therapy lozenges; (4) Nicotine replacement therapy nasal spray; (5) Nicotine replacement therapy inhalers; (6) Bupropion; and (7) Varenicline. (b) Prior authorization shall not be required for coverage of medications described in subsection (a) of this section. Added by Act 2019, No. 959,§ 2, eff. 7/24/2019. (a) The Department of Human Services shall ensure that the Arkansas Medicaid Program covers medications approved by the United States Food and Drug Administration for tobacco cessation, including without limitation: (1) Nicotine replacement therapy patches; (2) Nicotine replacement therapy gum; (3) Nicotine replacement therapy lozenges; (4) Nicotine replacement therapy nasal spray; (5) Nicotine replacement therapy inhalers; (6) Bupropion; and (7) Varenicline. (1) Nicotine replacement therapy patches; (2) Nicotine replacement therapy gum; (3) Nicotine replacement therapy lozenges; (4) Nicotine replacement therapy nasal spray; (5) Nicotine replacement therapy inhalers; (6) Bupropion; and (7) Varenicline. (b) Prior authorization shall not be required for coverage of medications described in subsection (a) of this section.
‹ Prev All Arkansas sections Next ›
Lexace provides legal information, not legal advice, and no attorney–client relationship is created. Statute text is provided for general information and may not reflect the most recent amendments; verify against the official state code.